AZO
50
-5
PEG
62
4
XYL
35
-2
PVH
60
-4
CRM
60
-7
DE
42
3
A
37
-2
TMO
42
-6
PG
50
2
RSG
65
-3
FAST
57
-3
WYNN
36
-5
LMT
30
-2
HAS
30
-2
URBN
48
-6
V
64
-2
AAP
35
-9
RHI
57
-6
ADP
65
-3
KR
36
-6
AZO
50
-5
PEG
62
4
XYL
35
-2
PVH
60
-4
CRM
60
-7
DE
42
3
A
37
-2
TMO
42
-6
PG
50
2
RSG
65
-3
FAST
57
-3
WYNN
36
-5
LMT
30
-2
HAS
30
-2
URBN
48
-6
V
64
-2
AAP
35
-9
RHI
57
-6
ADP
65
-3
KR
36
-6
Financhill
Back

iShares MSCI Poland ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
53

EPOL
iShares MSCI Poland ETF

Last Price:
21.74
Seasonality Move:
1.92%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
53
iShares MSCI Poland ETF (EPOL) is a Buy

Is iShares MSCI Poland ETF a Buy, Sell or Hold?

  • The current iShares MSCI Poland ETF [EPOL] share price is $21.74. The Score for EPOL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • EPOL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EPOL Stock Price Chart

What is iShares MSCI Poland ETF's stock price today?

  • The iShares MSCI Poland ETF share price today is $21.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPOL is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EPOL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 38.24 Sell
Chaikin Money Flow: -28797 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.1 - 23.16) Sell
Bollinger Bands (100): (22.79 - 24.65) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EPOL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.37 Sell
20-day SMA: 22.43 Sell
50-day SMA: 23.27 Sell
200-day SMA: 23.75 Sell
8-day EMA: 22.21 Sell
20-day EMA: 22.53 Sell
50-day EMA: 23.06 Sell
200-day EMA: 23.11 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares MSCI Poland ETF Earnings Growth & EPOL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

iShares MSCI Poland ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):